Skip to main content

Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Edwards Lifesciences Upgraded To Market Perform
Joe Young  
 
September 27, 2010 10:03am   Comments
Share:

Rodman & Renshaw has upgraded Edwards Lifesciences (NYSE: EW) from Market Underperform to Market Perform.

Edwards Lifesciences closed Friday at $67.91.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 

Related Articles (EW)

Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027
How Do Investors Really Feel About Edwards Lifesciences?
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
US Stocks Hit New Highs As Magnificent Seven Reach $19 Trillion: What's Moving Markets Friday?
Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results
6 Analysts Assess Edwards Lifesciences: What You Need To Know
View Comments and Join the Discussion!

Posted-In: Edwards Lifesciences Rodman & RenshawUpgrades Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com